Etanercept: a clinical review of current and emerging indications.

@article{Nanda2004EtanerceptAC,
  title={Etanercept: a clinical review of current and emerging indications.},
  author={Shikha M Nanda and Joan M. Bathon},
  journal={Expert opinion on pharmacotherapy},
  year={2004},
  volume={5 5},
  pages={1175-86}
}
The recent development of inhibitors of TNF-alpha has provided the opportunity for a more targeted and highly effective approach to the treatment of chronic inflammatory illnesses such as rheumatoid arthritis. Since the initial approval of etanercept as a treatment for rheumatoid arthritis, additional indications, including psoriatic arthritis, juvenile rheumatoid arthritis and ankylosing spondylitis, have also received FDA approval. More than 220,000 patients have been treated with etanercept… CONTINUE READING

From This Paper

Topics from this paper.
14 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Similar Papers

Loading similar papers…